Exacerbation of experimental pyelonephritis by cyclosporin A

References

1. Bunjes D., Hardt C., Rollinghoff M., Wagner H. 1981; Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. European Journal of Immunology 11:657–661
   [Google Scholar]
2. Douglas-Jones A., Nelson J., Jansen V., Miller T. 1981; Characterization of the (rnu^nz) nude rat. Morphological characteristics of the lymphoid system. Australian Journal of Experimental Biology and Medical Science 59:277–286
   [Google Scholar]
3. Hess A. D., Colombani P. M., Esa A. H. 1986; Cyclosporine and the immune response: basic aspects. CRC Critical Reviews in Immunology 6:123–149
   [Google Scholar]
4. Janco R. L., English D. 1983; Cyclosporine and human neutrophil function. Transplantation 35:501–503
   [Google Scholar]
5. Kahan B. D. 1985; Cyclosporine: the agent and its actions. Transplantation Proceedings 17: Suppl 15–18
   [Google Scholar]
6. Loliger C., Lehmann-Grube F. 1985; Mechanism of recovery from acute virus infection. II. Effect of treatment of mice with cyclosporin A on their ability to eliminate the lymphocytic choriomeningitis virus. Medical Microbiology and Immunology 174:187–196
   [Google Scholar]
7. Marshall E., Miller T. 1981; Characterization of the nude rat (rnu^nz). Functional characteristics. Australian Journal of Experimental Biology and Medical Science 59:287–296
   [Google Scholar]
8. Miller T. E., Findon G. 1985; Experimental candidosis: paw oedema in the analysis of a local infection. Journal of Medical Microbiology 20:283–290
   [Google Scholar]
9. Miller T. E., Findon G. 1986; Modulation of host defenses against pyogenic microorganisms by cyclosporine. Transplantation 42:463–466
   [Google Scholar]
10. Miller T. E., Findon G., Cawley S., Clarke I. 1986; Cellular basis of host defence in pyelonephritis. II. Acute infection. British Journal of Experimental Pathology 67:191–200
    [Google Scholar]
11. MillerT E., Robinson K. B. 1973; Experimental pyelonephritis: a new method for inducing pyelonephritis in the rat. Journal of Infectious Diseases 127:307–310
    [Google Scholar]
12. Moffat F. L. 1985; Reversal of cyclosporine-induced mortality with a synthetic polymeric immunostimulant in a murine model of fecal peritonitis. Transplantation 39:369–374
    [Google Scholar]
13. Murray B. M., Paller M. S., Ferris T. F. 1985; Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney International 28:767–774
    [Google Scholar]
14. Najarian J. S. 1983; Comparison of cyclosporine versus azathioprine-antilymphocyte globulin in renal transplantation. Transplantation Proceedings 15:2463–2468
    [Google Scholar]
15. Ormrod D. J., Cawley S., Miller T. E. 1985; Extended immunosuppression with cyclophosphamide using controlled-release polymeric implants. International Journal of Immunopharmacology 7:443–448
    [Google Scholar]
16. Oyer P. E. 1983; Cyclosporine in cardiac transplantation: a 2j year follow-up. Transplantation Proceedings 15:2546–2552
    [Google Scholar]
17. Perfect J. R., Durack D. T. 1985; Effects of cyclosporine in experimental cryptococcal meningitis. Infection and Immunity 50:22–26
    [Google Scholar]
18. Schaffner A., Douglas H., Davis C. E. 1983; Models of T cell deficiency in listeriosis: the effects of cortisone and cyclosporin A on normal and nude BALB/c mice. Journal of Immunology 131:450–453
    [Google Scholar]
19. Sells R. A. 1983; A prospective randomized substitutive trial of cyclosporine as a prophylactic agent in human renal transplant rejection. Transplantation Proceedings 15:2495–2500
    [Google Scholar]
20. Shiel A. G. R. 1983; Australian trial of cyclosporine (CsA) in cadaveric donor renal transplantation. Transplantation Proceedings 15:2485–2489
    [Google Scholar]
21. Thomson A. W., Whiting P. H., Cameron I. D., Lessels S. E., Simpson J. G. 1981; A toxicological study in rats receiving immunotherapeutic doses of cyclosporin A. Transplantation 31:121–124
    [Google Scholar]